Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL2300576	重组抗CTLA-4全人单克隆抗体注射液	Injection	Biological Products(3.3)	New Drug Application	2023-08-26		Shanghai Henlius Biopharmaceutical Co Ltd			view
CXSL2300265	重组抗CTLA-4全人单克隆抗体注射液	Injection	Biological Products(3.3)	New Drug Application	2023-04-18		Shanghai Henlius Biopharmaceutical Co Ltd			view
CXSB2200080	重组抗CTLA-4全人单克隆抗体注射液	Injection	Biological Products(原2)	Supplementary Application	2022-09-27		Shanghai Henlius Biotech Co Ltd			view
CXSL2000004	重组抗CTLA-4全人单克隆抗体注射液	Injection	Biological Products(2)	New Drug Application	2020-01-15	上海复宏汉霖生物制药有限公司	Shanghai Henlius Biopharmaceutical Co Ltd	In Review	2020-01-14	view